GlassScriptPhysician profile
Sharon De Edwards
NPI 1548295975
$4,593.41
in general payments reported to CMS, 2019-2025
24 companies · $442 in 2025
The $442 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,197 · 2020: $239 · 2021: $493 · 2022: $492 · 2023: $385 · 2024: $346 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,040 · Education: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,040.22 |
| Education | $132.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,383.09 | 2019 | |
| Abbvie INC. | $946.30 | 2019-2023 | Orilissa |
| Astellas Pharma US INC | $472.79 | 2023-2025 | Veozah |
| Stryker Corporation | $329.48 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $203.16 | 2023-2024 | Exparel |
| Pfizer INC. | $185.47 | 2019-2024 | |
| Amag Pharmaceuticals, INC. | $160.65 | 2019-2020 | |
| Exeltis, USA INC. | $127.55 | 2025 | Slynd, Twirla |
| Conmed Corporation | $117.08 | 2022 | |
| Organon LLC | $103.30 | 2021-2025 | Nexplanon |
| Intuitive Surgical, INC. | $100.41 | 2022 | |
| Roche Diagnostics Corporation | $91.65 | 2019-2021 | |
| Avion Pharmaceuticals | $77.23 | 2019-2021 | |
| Ethicon US, LLC | $46.83 | 2022 | |
| Mayne Pharma Commercial LLC | $39.79 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $32.21 | 2020-2024 | Aptima |
| Davol INC. | $29.27 | 2022 | |
| Sumitomo Pharma America, INC. | $25.83 | 2023 | Myfembree |
| Focal Therapeutics, INC. | $25.67 | 2019 | |
| Olympus America INC. | $24.30 | 2019 | |
| Coopersurgical, INC. | $21.17 | 2025 | Paragard T 380a |
| Meditrina | $17.86 | 2024 | |
| Myovant Sciences INC. | $17.19 | 2022 | |
| Minerva Surgical, INC | $15.13 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon De Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.